Eterna Therapeutics's market cap is currently $15.57M. The company's EPS TTM is $-8.308; its P/E ratio is ―; Eterna Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 68.00K	$ 0.00	$ 0.00	$ 0.00	$ 19.81M
Gross Profit	$ -168.00K	$ -497.00K	$ -459.00K	$ -98.00K	$ 11.96M
Operating Income	$ -21.14M	$ -33.22M	$ 68.34M	$ -7.25M	$ -1.21M
EBITDA	$ -19.93M	$ -33.22M	$ -121.95M	$ -7.15M	$ 1.96M
Net Income	$ -21.67M	$ -24.58M	$ -122.31M	$ 11.91M	$ -2.05M
Balance Sheet
Cash & Short-Term Investments	$ 7.58M	$ 11.45M	$ 16.98M	$ 1.63M	$ 3.26M
Total Assets	$ 49.13M	$ 22.28M	$ 32.43M	$ 12.91M	$ 15.28M
Total Debt	$ 41.84M	$ 4.14M	$ 2.72M	$ 2.90M	$ 6.08M
Net Debt	$ 34.27M	$ -7.31M	$ -14.26M	$ 1.27M	$ 2.82M
Total Liabilities	$ 46.90M	$ 10.17M	$ 25.93M	$ 5.25M	$ 10.19M
Stockholders' Equity	$ 2.23M	$ 12.11M	$ 6.50M	$ 7.66M	$ 5.09M
Cash Flow
Free Cash Flow	$ -20.43M	$ -21.27M	$ -23.64M	$ -8.14M	$ 1.65M
Operating Cash Flow	$ -20.41M	$ -20.98M	$ -23.49M	$ -8.10M	$ 2.74M
Investing Cash Flow	$ -19.00K	$ -47.00K	$ -22.74M	$ -39.00K	$ -1.06M
Financing Cash Flow	$ 16.56M	$ 19.58M	$ 61.59M	$ 4.67M	$ -1.10M

Currency in USD

Eterna Therapeutics Earnings and Revenue History

Income Statement >

Eterna Therapeutics Debt to Assets

Balance Sheet >

Eterna Therapeutics Cash Flow

Cash Flow >

Eterna Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing